Urinary biomarkers involved in type 2 diabetes: a review. - Wikidata - wikimedia - TriplyDB

Urinary biomarkers involved in type 2 diabetes: a review.

Urinary biomarkers involved in type 2 diabetes: a review.

http://www.wikidata.org/entity/Q37707267

about

Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys?The urine microRNA profile may help monitor post-transplant renal graft function.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.Assessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patients Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.Identifying module biomarker in type 2 diabetes mellitus by discriminative area of functional activity.Two urinary peptides associated closely with type 2 diabetes mellitus.Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients.Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study.Urinary markers of glomerular injury in diabetic nephropathy Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans.Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes A porphyrin-PEG polymer with rapid renal clearance Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.Elevated Levels of Urinary Markers of Oxidative DNA and RNA Damage in Type 2 Diabetes with Complications Urinary proteomics for early diagnosis in diabetic nephropathy.Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study.Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease.Value of the combined examination of Cys-C and HbA1c for diagnosis of early renal injury in pediatric diabetes.Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.The role of novel biomarkers in predicting diabetic nephropathy: a review.Urinary proteome analysis in congenital bilateral hydronephrosis.Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.Urine AQP5 is a potential novel biomarker of diabetic nephropathy.Assessment of the Therapeutic Potential of Persimmon Leaf Extract on Prediabetic Subjects.Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria.Determination of urinary 8-hydroxy-2'-deoxyguanosine by a combination of on-line molecularly imprinted monolithic solid phase microextraction with high performance liquid chromatography-ultraviolet detection.Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.

P2860

Q26740305-1BF928C8-1D93-475A-B6B0-710958CFCEC2 Q26744419-7ADDFA73-FE2A-40E1-8F8A-57B9F2941A66 Q28478051-57A42041-E56D-490F-8167-4EFA46D5F4D1 Q30411597-EC06D947-F161-4B53-BBEB-CC212CDFF081 Q33772238-5F3C8181-0AF9-4488-9982-12BBF5273C09 Q34924389-9EF6B68E-F5C8-42FC-B0A7-A132CD7D3C4F Q35021685-E6F65382-829E-4EF5-BB0D-CE630D74BF84 Q35054853-BBC2042D-48C8-456A-B533-1BF37BAD84AB Q35218961-5FC0FEC4-C2C4-4701-9F61-FBCA009010A2 Q35527005-E604ED82-9D8B-450B-B0DC-C802C864D0D6 Q35563607-A5FD01B1-4707-4E59-9376-D64801C81810 Q35868599-6B132BFC-E4C9-4153-B774-3D9A2D0A566C Q35878999-BC497D53-7FE6-4291-8C69-7AAE8C48C4BA Q35903097-AB4AC9E0-F961-49BE-9F7F-87D592D1EC39 Q35924547-804FAEE2-1C37-4360-B0C7-C96D215811CC Q35974945-1E9DDEA3-9D65-4CB3-8A37-B5C38A6C94E3 Q36206558-E8F95D5A-B057-45E0-A1C2-10D669B11949 Q36236725-88C9C790-B5A2-4238-A9BD-A49B42C041DF Q36327636-E0E0E272-D7E7-4432-9108-2134944D2DA3 Q36328641-E5B177C4-3368-4B6F-932F-2A88823BB40E Q36387626-B8F4F2B5-56C2-4967-8656-014B3334E10C Q36410737-ADE7225A-66DB-4056-94AB-82D82CCC394E Q36629471-C2705A3A-3370-48E0-9C3B-9BABB9C33F64 Q36629664-120E21B6-09C7-4CF6-8B45-711FD0FF4C68 Q36780412-8D1F1C98-180D-49DD-ACD1-61F5B112ED3C Q36968011-3C79E01C-D8A5-41C2-8A7C-C7E8822FE8BF Q37559421-97E407DC-24CC-4915-8E2A-30E54FF1D565 Q37611255-3C7B3299-2689-426F-902B-1F493D21F0C0 Q37697731-F0E9845D-1AA3-47C8-8BCC-7C4045DD331F Q37972817-769B8A41-B775-47CF-A353-931D02B723CE Q38053941-BEAA4D56-2299-4E67-8FB9-0DA0C62FABF7 Q38598929-4BD839A9-3A9C-456F-BFAF-A035A339B5D2 Q39243554-B47F5D6D-9BB1-45F9-AE26-1314B605EB5C Q39427404-B9D2926E-DE53-424F-B8E5-D744DDB72A5A Q39831322-986B6DCB-72FA-426F-B183-EF27F68722A8 Q41288575-FF4B5708-D04A-4937-9EA9-69E95A64B661 Q42352782-C62965D6-B420-4E58-A3E6-8685D6E2D11B Q42373908-11C29FCE-786A-4548-9821-2D609E0B3EE2 Q43454257-750FC1B7-13B4-4029-ADC9-04693CEB96B7 Q43479634-C0771F60-9598-4751-BC3D-206ACBA175C4

P2860

Urinary biomarkers involved in type 2 diabetes: a review.

http://www.wikidata.org/entity/Q37707267

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Urinary biomarkers involved in type 2 diabetes: a review.

@en

Urinary biomarkers involved in type 2 diabetes: a review.

@nl

type

label

Urinary biomarkers involved in type 2 diabetes: a review.

@en

Urinary biomarkers involved in type 2 diabetes: a review.

@nl

prefLabel

Urinary biomarkers involved in type 2 diabetes: a review.

@en

Urinary biomarkers involved in type 2 diabetes: a review.

@nl

P1433

Q37707267-6C8CD941-DCBB-4CB0-A94E-59E8EC210293

P1476

Q37707267-E2F13349-51E2-4C74-A382-A3A40EBC10C4

P2093

Q37707267-126FE346-3287-47DE-B003-7EFD1AAD7AD9

Q37707267-874D64DB-361B-47B0-8FC3-F2094620E031

P2860

Q37707267-4048B2C6-F9D6-4433-87AD-56C8CD662123

Q37707267-62BFA6C2-5FDF-409C-823D-53A70FDAE49F

Q37707267-9B4D293C-91FE-43F2-BA48-61F5104D7362

Q37707267-B0F6705C-27BA-45E4-B31B-A5EA86706DD7

Q37707267-B6AB49F5-7379-4A18-8D67-070B0FE1E7D3

Q37707267-BC59F333-1986-4856-A6D7-08EC48BF5F21

Q37707267-C3890160-7B4C-4C81-BE3F-ACCD8E8B10D2

Q37707267-DEB5AF49-71DE-49CA-B588-A68AE0B7A2B6

Q37707267-F6012989-EBC6-46F7-9F27-D5F51EC6DCE9

Q37707267-F92BAE88-219E-4186-BB1B-4B63F757477C

P304

Q37707267-A0DB6AC7-C650-4A75-8B75-AB3F8F1CBCA1

P31

Q37707267-9B4D57B9-774D-42BD-9F6B-6E84E5B9C869

P356

Q37707267-4FA90CCC-F58B-4F89-905E-2CFCFF1D5B40

P433

Q37707267-85C831DB-6C6E-4AFD-B8D2-30CBDBE91703

P478

Q37707267-54673ED6-F503-486D-B403-D13D068E98FF

P50

Q37707267-4C73CB4B-E805-4ECF-9244-E1D2D98169DD

Q37707267-E9D1F2AF-162B-41EB-BD78-55B8F7EE4A5E

P577

Q37707267-91866833-76E0-4587-A88A-13B6AF945EA4

P5875

Q37707267-7F5ADA73-73B0-441A-9339-00B396E2838C

P698

Q37707267-EA377272-6CD3-481A-99DC-D080E6F42DE5

P921

Q37707267-1897F241-C8D6-4144-9877-D0E938B16B33

Q37707267-7704D59A-A79B-45F5-83FE-21510AA091F6

P356

P1433

Diabetes - Metabolism: Research and Reviews

P1476

Urinary biomarkers involved in type 2 diabetes: a review

@en

P2093

Agnès Matheson

http://www.w3.org/2001/XMLSchema#string

Judith Flanagan

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

Tests of glycemia for the diagnosis of type 2 diabetes mellitus.

Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management.

Screening for type 2 diabetes: literature review and economic modelling.

The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.

Transferrinuria in type 2 diabetes: the effect of glycaemic control.

Urinary enzyme measurements as early indicators of renal insult in type 2 diabetes.

Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes.

Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality.

Platelet volume and urinary prostanoid metabolites in non-insulin-dependent diabetes mellitus.

P304

150-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DMRR.1068

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Bradley J. Walsh

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41896832

http://www.w3.org/2001/XMLSchema#string

P698

20222150

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes